InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer Pharmaceutical Investing
Notice of Knight Therapeutics' Fourth Quarter and Year End 2022 Results Conference Call Pharmaceutical Investing
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature Pharmaceutical Investing
Medtronic receives CE Mark approval for Affera Mapping and Ablation System to treat atrial arrhythmias Medical Device Investing
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc. Pharmaceutical Investing
Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion Pharmaceutical Investing
Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies Medical Device Investing
Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial Medical Device Investing
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems Pharmaceutical Investing